2025年內分泌胜肽檢測全球市場報告

預計未來幾年內分泌肽檢測市場規模將強勁成長。到 2029 年，這一數字將成長至 142.2 億美元，複合年成長率為 9.3%。預測期內的成長歸因於內分泌肽測試需求的增加、研發活動的成長、文明病的增加、老年人口的增加以及人群中糖尿病患病率的上升。預測期內的關鍵趨勢包括內分泌檢測方法的進步、產品技術的進步、開發新型檢測解決方案的研發活動的活性化、產品核可數量的增加以及向預防性醫療保健的轉變。

糖尿病盛行率的不斷上升預計將推動內分泌肽檢測市場的擴張。糖尿病是指以血糖值（葡萄糖）水平升高為特徵的多種疾病。糖尿病病例的增加歸因於不良飲食、久坐的生活方式、遺傳因素和人口老化等因素。內分泌肽測試，包括糖化血紅蛋白、空腹血糖和 C 肽測試，用於診斷糖尿病、監測血糖濃度以及評估胰島素的產生和敏感性。例如，2024 年 6 月，英國政府機構國家醫療服務體系 (NHS) 報告稱，40 歲以下確診患有糖尿病的人數顯著增加，從 2022 年的 173,166 人增加到 2023 年的 216,440 人。這一顯著成長凸顯了一個令人擔憂的趨勢：年輕族群糖尿病發生率的上升。因此，糖尿病盛行率的上升正在推動內分泌肽檢測市場的成長。

內分泌肽檢測市場的主要企業正在開發免疫檢測測定檢測系統，以提高準確性、靈敏度和速度。這些系統使用抗體來檢測和量化血液和尿液樣本中的特定胜肽，為醫療保健專業人員提供有關荷爾蒙水平和內分泌功能的重要見解。例如，2023 年 7 月，西門子 Hertinies 宣布推出 Atellica CI 分析儀，這是一種緊湊型系統，能夠進行免疫檢測和臨床化學測試，包括內分泌胜肽測定。該診所提供生殖內分泌學菜單，包括用於評估卵巢儲備的抗苗勒氏管激素 (AMH) 等測試，以及用於妊娠毒血症的 sFlt-1 和 PlGF 等測試。 Atellica CI 分析儀每小時可進行多達 1,000 次測試，提供快速、一致、高品質的結果，幫助實驗室滿足不斷變化的測試需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球內分泌胜肽檢測PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球內分泌胜肽檢測市場：成長率分析
• 全球內分泌肽檢測市場表現：規模與成長，2019-2024
• 全球內分泌肽檢測市場預測：規模與成長，2024-2029，2034F
• 全球內分泌胜肽檢測總目標市場（TAM）

第6章市場區隔

• 全球內分泌肽檢測市場（依檢測類型、效能及預測），2019-2024 年、2024-2029 年、2034 年
• 脫氫表雄酮硫酸鹽
• 孕酮
• 黃體激素
• 甲狀腺催乳素
• 雌二醇
• 人類絨毛膜促性腺激素分泌
• 甲狀腺刺激素
• 其他測試類型
• 全球內分泌肽檢測市場（按技術、性能和預測）：2019-2024 年、2024-2029 年、2034 年
• 質譜法
• 免疫檢測
• 層析法
• 基於核酸
• 其他技術
• 全球內分泌肽檢測市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 診所
• 醫療保健中心
• 醫院
• 商業研究所
• 全球內分泌胜肽檢測市場：硫酸脫氫表雄酮（DHEA-S）細分市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 免疫檢測
• 酵素免疫分析法（ELISA）
• 免疫測量（RIA）
• 全球內分泌肽檢測市場孕酮細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 免疫檢測
• 化學冷光分析
• ELISA檢測
• 全球內分泌肽檢測市場黃體激素(LH) 細分市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 免疫檢測
• 酵素免疫分析法（EIA）
• 免疫測量（RIA）
• 全球內分泌胜肽檢測市場甲狀腺催乳素細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 免疫檢測
• 化學冷光分析
• 免疫測量（RIA）
• 全球內分泌肽檢測市場雌二醇細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 免疫檢測
• 酵素免疫分析法（ELISA）
• 免疫測量（RIA）
• 全球內分泌胜肽檢測市場人類絨毛膜促性腺激素分泌(hCG) 細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 免疫檢測
• 化學冷光分析
• 酵素免疫分析法（EIA）
• 全球內分泌肽檢測市場甲狀腺刺激素(TSH) 細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 免疫檢測
• 免疫測量（RIA）
• 酵素免疫分析法（ELISA）
• 全球內分泌肽檢測市場，按其他檢測類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 皮質醇
• 胰島素
• 生長激素（GH）
• 副甲狀腺素（PTH）

第7章 區域和國家分析

• 全球內分泌胜肽檢測市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球內分泌胜肽檢測市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 內分泌胜肽檢測市場：競爭格局
• 內分泌胜肽檢測市場：公司簡介
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Laboratory Corporation of America Holdings（LabCorp）
• Quest Diagnostics Incorporated
• Agilent Technologies Inc.
• Illumina Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• Sciex
• Bio-Techne Corporation
• Invitae Corporation
• ARUP Laboratories
• Genova Diagnostics
• Boston Heart Diagnostics Corporation
• Immunodiagnostic Systems Ltd.
• Mayo Clinic Laboratories

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年內分泌胜肽檢測市場：提供新機會的國家
• 2029年內分泌肽檢測市場：細分領域帶來新機會
• 2029年內分泌胜肽檢測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

The endocrine peptide test is a diagnostic procedure used to assess levels of specific peptides in blood or urine, crucial for monitoring the endocrine system's function and detecting related disorders. It primarily focuses on measuring peptide hormones in blood to diagnose and track endocrine disorders.

Key tests in the endocrine peptide market include dehydroepiandrosterone sulfate (DHEAS), progesterone, luteinizing hormone, thyroid prolactin, estradiol, human chorionic gonadotropin, thyroid-stimulating hormone, among others. The DHEAS test specifically measures DHEAS levels in the bloodstream. Technologies employed include mass spectroscopy, immunoassay, chromatography, nucleic acid-based methods, and others. End users include clinics, healthcare centers, hospitals, and commercial laboratories.

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing government spending, rising prevalence of diabetes, decreasing level of immunity in people across the world, high risk of contracting any chronic diseases, and rising government initiatives.

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for endocrine peptide test, growth in research and development activities, rise in number of lifestyle diseases, increasing geriatric population, and rising prevalence of diabetes amongst the masses. Major trends in the forecast period include advancement in the endocrine testing method, advancements in product technologies, increasing research and development activities to develop novel testing solutions, growing number of product approval, and shift towards preventive healthcare.

The growing prevalence of diabetes is expected to drive the expansion of the endocrine peptide test market. Diabetes refers to a range of conditions characterized by elevated blood sugar (glucose) levels. The rise in diabetes cases is attributed to factors such as poor diets, sedentary lifestyles, genetic factors, and an aging population. Endocrine peptide tests, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are used to diagnose diabetes, monitor glucose levels, and evaluate insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported a notable increase in the number of individuals under 40 diagnosed with diabetes, rising from 173,166 in 2022 to 216,440 in 2023. This significant increase highlights the concerning trend of rising diabetes cases among younger individuals. Therefore, the increasing prevalence of diabetes is fueling the growth of the endocrine peptide test market.

Leading companies in the endocrine peptide test market are advancing immunoassay testing systems to enhance accuracy, sensitivity, and speed. These systems employ antibodies to detect and quantify specific peptides in blood or urine samples, providing healthcare professionals with essential insights into hormone levels and endocrine function. For example, Siemens Healthineers introduced the Atellica CI Analyzer in July 2023, a compact system capable of immunoassay and clinical chemistry testing, including endocrine peptide assays. It features a reproductive endocrinology menu with tests such as anti-Mullerian hormone (AMH) for ovarian reserve assessment and sFlt-1 and PlGF for preeclampsia prognosis. With a capacity of up to 1000 tests per hour, the Atellica CI Analyzer ensures rapid and consistent delivery of high-quality results, supporting laboratories in meeting evolving testing demands.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics to bolster its portfolio in pediatric endocrinology and men's health. Jatenzo, a testosterone replacement therapy, complements Tolmar's specialty pharmaceutical products, enhancing their offerings for individuals with endocrine disorders. Clarus Therapeutics, known for developing therapies in this field, facilitated the acquisition, expanding Tolmar's market presence and therapeutic capabilities.

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Peptide Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine peptide test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine peptide test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine peptide test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test-Type: Dehydroepiandrosterone Sulphate; Progesterone; Luteinizing Hormone; Thyroid Prolactin; Oestradiol; Human Chorionic Gonadotropin; Thyroid-Stimulating Hormone; Other Test-Types
• 2) By Technology: Mass Spectroscopy; Immunoassay; Chromatography; Nucleic Acid Based; Other Technologies
• 3) By End-User: Clinics; Healthcare Centers; Hospitals; Commercial Laboratories
• Subsegments:
• 1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
• 2) By Progesterone: Immunoassay Tests; Chemiluminescence Assays; ELISA Tests
• 3) By Luteinizing Hormone (LH): Immunoassay Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (RIA)
• 4) By Thyroid Prolactin: Immunoassay Tests; Chemiluminescence Assays; Radioimmunoassay (RIA)
• 5) By Oestradiol: Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
• 6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests; Chemiluminescence Assays; Enzyme Immunoassay (EIA)
• 7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests; Radioimmunoassay (RIA); Enzyme-Linked Immunosorbent Assay (ELISA)
• 8) Other Test-Types: Cortisol; Insulin; Growth Hormone (GH); Parathyroid Hormone (PTH)
• Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Peptide Test Market Characteristics

3. Endocrine Peptide Test Market Trends And Strategies

4. Endocrine Peptide Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endocrine Peptide Test Growth Analysis And Strategic Analysis Framework

• 5.1. Global Endocrine Peptide Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Endocrine Peptide Test Market Growth Rate Analysis
• 5.4. Global Endocrine Peptide Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Endocrine Peptide Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Endocrine Peptide Test Total Addressable Market (TAM)

6. Endocrine Peptide Test Market Segmentation

• 6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dehydroepiandrosterone Sulphate
• Progesterone
• Luteinizing Hormone
• Thyroid Prolactin
• Oestradiol
• Human Chorionic Gonadotropin
• Thyroid-Stimulating Hormone
• Other Test-Types
• 6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass Spectroscopy
• Immunoassay
• Chromatography
• Nucleic Acid Based
• Other Technologies
• 6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Healthcare Centers
• Hospitals
• Commercial Laboratories
• 6.4. Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• 6.5. Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Chemiluminescence Assays
• ELISA Tests
• 6.6. Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Enzyme Immunoassay (EIA)
• Radioimmunoassay (RIA)
• 6.7. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Chemiluminescence Assays
• Radioimmunoassay (RIA)
• 6.8. Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• 6.9. Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Chemiluminescence Assays
• Enzyme Immunoassay (EIA)
• 6.10. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Radioimmunoassay (RIA)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• 6.11. Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cortisol
• Insulin
• Growth Hormone (GH)
• Parathyroid Hormone (PTH)

7. Endocrine Peptide Test Market Regional And Country Analysis

• 7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Peptide Test Market

• 8.1. Asia-Pacific Endocrine Peptide Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Peptide Test Market

• 9.1. China Endocrine Peptide Test Market Overview
• 9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Peptide Test Market

• 10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Peptide Test Market

• 11.1. Japan Endocrine Peptide Test Market Overview
• 11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Peptide Test Market

• 12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Peptide Test Market

• 13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Peptide Test Market

• 14.1. South Korea Endocrine Peptide Test Market Overview
• 14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Peptide Test Market

• 15.1. Western Europe Endocrine Peptide Test Market Overview
• 15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Peptide Test Market

• 16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Peptide Test Market

• 17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Peptide Test Market

• 18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Peptide Test Market

• 19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Peptide Test Market

• 20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Peptide Test Market

• 21.1. Eastern Europe Endocrine Peptide Test Market Overview
• 21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Peptide Test Market

• 22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Peptide Test Market

• 23.1. North America Endocrine Peptide Test Market Overview
• 23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Peptide Test Market

• 24.1. USA Endocrine Peptide Test Market Overview
• 24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Peptide Test Market

• 25.1. Canada Endocrine Peptide Test Market Overview
• 25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Peptide Test Market

• 26.1. South America Endocrine Peptide Test Market Overview
• 26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Peptide Test Market

• 27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Peptide Test Market

• 28.1. Middle East Endocrine Peptide Test Market Overview
• 28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Peptide Test Market

• 29.1. Africa Endocrine Peptide Test Market Overview
• 29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

• 30.1. Endocrine Peptide Test Market Competitive Landscape
• 30.2. Endocrine Peptide Test Market Company Profiles
  • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Peptide Test Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings (LabCorp)
• 31.2. Quest Diagnostics Incorporated
• 31.3. Agilent Technologies Inc.
• 31.4. Illumina Inc.
• 31.5. bioMerieux SA
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. DiaSorin S.p.A.
• 31.8. Sciex
• 31.9. Bio-Techne Corporation
• 31.10. Invitae Corporation
• 31.11. ARUP Laboratories
• 31.12. Genova Diagnostics
• 31.13. Boston Heart Diagnostics Corporation
• 31.14. Immunodiagnostic Systems Ltd.
• 31.15. Mayo Clinic Laboratories

32. Global Endocrine Peptide Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

34. Recent Developments In The Endocrine Peptide Test Market

35. Endocrine Peptide Test Market High Potential Countries, Segments and Strategies

• 35.1 Endocrine Peptide Test Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Endocrine Peptide Test Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Endocrine Peptide Test Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer